Correlation Between NewAmsterdam Pharma and Allovir
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Allovir, you can compare the effects of market volatilities on NewAmsterdam Pharma and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Allovir.
Diversification Opportunities for NewAmsterdam Pharma and Allovir
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NewAmsterdam and Allovir is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Allovir go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Allovir
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.47 times more return on investment than Allovir. However, NewAmsterdam Pharma is 2.13 times less risky than Allovir. It trades about 0.12 of its potential returns per unit of risk. Allovir is currently generating about -0.16 per unit of risk. If you would invest 1,782 in NewAmsterdam Pharma on September 2, 2024 and sell it today you would earn a total of 203.00 from holding NewAmsterdam Pharma or generate 11.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Allovir
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Allovir |
NewAmsterdam Pharma and Allovir Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Allovir
The main advantage of trading using opposite NewAmsterdam Pharma and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Allovir vs. Anebulo Pharmaceuticals | Allovir vs. Mineralys Therapeutics, Common | Allovir vs. AN2 Therapeutics | Allovir vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |